Pernix Therapeutics Holdings (PTX) Reaches $4.01 After 7.00% Down Move; Steinberg Asset Management Has Cut Its Golar Lng Partners LP (GMLP) Stake

May 29, 2017 - By Vivian Park

The stock of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) is a huge mover today! The stock decreased 6.74% or $0.29 on May 26, reaching $4.01. About 298,110 shares traded. Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has risen 9.00% since May 29, 2016 and is uptrending. It has underperformed by 7.70% the S&P500.The move comes after 6 months negative chart setup for the $37.45 million company. It was reported on May, 29 by Barchart.com. We have $3.73 PT which if reached, will make NASDAQ:PTX worth $2.62 million less.

Steinberg Asset Management Llc decreased Golar Lng Partners Lp (GMLP) stake by 15.2% reported in 2016Q4 SEC filing. Steinberg Asset Management Llc sold 77,150 shares as Golar Lng Partners Lp (GMLP)’s stock declined 10.22%. The Steinberg Asset Management Llc holds 430,360 shares with $10.35 million value, down from 507,510 last quarter. Golar Lng Partners Lp now has $1.39 billion valuation. The stock decreased 0.15% or $0.03 on May 26, reaching $20.32. About 125,225 shares traded. Golar LNG Partners LP (NASDAQ:GMLP) has risen 23.40% since May 29, 2016 and is uptrending. It has outperformed by 6.70% the S&P500.

Among 4 analysts covering Pernix Therapeutics (NASDAQ:PTX), 1 have Buy rating, 0 Sell and 3 Hold. Therefore 25% are positive. Pernix Therapeutics had 9 analyst reports since August 7, 2015 according to SRatingsIntel. JMP Securities reinitiated the stock with “Market Outperform” rating in Wednesday, September 9 report. The firm earned “Buy” rating on Tuesday, February 9 by Brean Capital. The firm has “Hold” rating given on Friday, August 12 by Brean Capital. Oppenheimer downgraded the shares of PTX in report on Thursday, March 17 to “Perform” rating. The rating was downgraded by Needham to “Hold” on Friday, March 11. The company was maintained on Friday, August 7 by Needham. The firm has “Buy” rating by Brean Capital given on Friday, March 11. The firm earned “Buy” rating on Friday, August 7 by Brean Capital.

Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company. The company has market cap of $37.45 million. The Firm focuses on identifying, developing and commercializing differentiated products that address unmet medical needs. It currently has negative earnings. It focuses on underserved therapeutic areas, such as central nervous system , including neurology and psychiatry, as well as other specialty therapeutic areas.

Among 4 analysts covering Golar LNG Partners (NASDAQ:GMLP), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Golar LNG Partners had 9 analyst reports since August 19, 2015 according to SRatingsIntel. The firm has “Hold” rating by Zacks given on Wednesday, August 19. The rating was initiated by Danske Bank with “Buy” on Tuesday, September 22. The stock of Golar LNG Partners LP (NASDAQ:GMLP) earned “Hold” rating by Stifel Nicolaus on Tuesday, January 3. The stock has “Buy” rating by Jefferies on Tuesday, September 13.